About Foresite Capital
Foresite Capital is a venture capital firm founded in 2011. It is primarily based out of New York City, United States. As of Feb 2025, Foresite Capital is an active investor, having invested in 200 companies, with 7 new investments in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it led the $225M Series B round of Seaport Therapeutics along with T. Rowe Price. This round also saw participation from Invus and other investors.
Overall, Foresite Capital portfolio has seen 5 unicorns, 82 IPOs and 57 acquisitions including key companies like Adaptive Biotechnologies, 10X Genomics and GRAIL. A lot of funds co-invest with Foresite Capital, with names like Orbimed sharing a substantial percentage of its portfolio.
Foresite Capital has team of 48 people including 18 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series C &
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Foresite Capital's Year-on-Year Investment Trends
Foresite Capital has invested in 201 companies over the last 13 years, with an average of 9 new investments annually in the last 10 years. In 2024, it made 16 investments, while as of Feb 2025, it has made 3 investments in this year. Its most recent first time investment was in Abcuro and most recent follow-on round was in Eikon.
Year | No. of Investments | ||
|---|---|---|---|
1stÌý¸é´Ç³Ü²Ô»å | Follow-on | Total | |
2025 (YTD) | 1 | 2 | 3 |
2024 | 9 | 7 | 16 |
2023 | 3 | 4 | 7 |
2022 | 6 | 8 | 14 |
2021 | 14 | 10 | 24 |
2020 | 21 | 12 | 33 |
2019 | 8 | 6 | 14 |
2018 | 13 | 3 | 16 |
2017 | 5 | 2 | 7 |
2016 | 1 | 3 | 4 |
Get Foresite Capital's portfolio delivered to your inbox!
Foresite Capital's Investment Trends by Stage
Foresite Capital has made 37 investments in Series B stage with an average round size of $67.1M, 25 investments in Series C stage with an average round size of $118M and 20 investments in Series A stage with an average round size of $81.6M.Note: We have considered here, only first round of investments
Stage of entry | No. of Investments |
|---|---|
Series B | 37 |
Series C | 25 |
Series A | 20 |
Post IPO | 8 |
Series D | 7 |
Others | 8 |
Foresite Capital's Investment Trends by Sector
Foresite Capital has a diverse portfolio, with companies operating in the Life Sciences, High Tech, HealthTech, Enterprise Applications and Sustainability Tech. Notably, it has invested in 181 Tech companies, 164 Enterprise (B2B) companies, 22 Software companies and at least 16 companies focusing on Tech hardware.
Note: We have considered here, only first round of investments
Sector | No. of Investments |
|---|---|
Life Sciences | 90 |
High Tech | 32 |
HealthTech | 15 |
Enterprise Applications | 13 |
Sustainability Tech | 7 |
Others | 19 |
Foresite Capital's Investment Trends by Geography
Foresite Capital has made most investments in United States (179), followed by United Kingdom where it has made 6 investments.
Note: We have considered here, only first round of investments
Country | No. of Investments |
|---|---|
United States | 94 |
United Kingdom | 6 |
Ireland | 2 |
China | 1 |
Israel | 1 |
Others | 1 |
Foresite Capital's recent investments
Here are the most recent investments by Foresite Capital:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 14, 2025 | United States | Series D | $351M | Lux Capital [+9] | |
Feb 07, 2025 | United States | Series C | $200M | [+12] | |
Jan 28, 2025 | United States | Series B | $150M | Blue Owl [+9] | |
Dec 23, 2024 | United States | Post IPO | $150M | TCG [+8] | |
Dec 12, 2024 | United States | Series B | $25M | [+1] |
Get the detailed list of all investments by Foresite Capital. Download now!Unicorns in Foresite Capital's Portfolio
Here is a list of unicorns in Foresite Capital's portfolio:
ÃØÃÜÑо¿Ëù Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
52 | Protein tracking and measuring tool for drug discovery | 2019 | Hayward | Series D | sucfixr | ||
57 | Provider of molecular diagnostics platform by using CRISPR technology | 2017 | San Francisco | Series D | mtzknkl | ||
62 | Provider of home-based diagnostic tests for the detection of various diseases | 2014 | Austin | Series D | fpcgiso | ||
67 | Developer of a saliva test kit to detect genetic risk of various disease for clinicians and individuals | 2013 | Burlingame | Series E | dlxjuqs | ||
33 | Provider of osmotic pump for subcutaneous drug delivery | 1995 | Boston | Series J | hwgky{u |
IPOs and Publicly Listed companies in Foresite Capital's Portfolio
Here are Foresite Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 31, 2025 | Mar 01, 2019 | Series C | $191M | |
Jun 28, 2024 | May 05, 2021 | Series A | $70M | |
Jun 25, 2024 | - | - | - | |
Jan 25, 2024 | Aug 01, 2023 | Series E | $105M | |
Dec 29, 2022 | - | - | - |
Acquired companies in Foresite Capital's Portfolio
Here are Foresite Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 30, 2025 | - | - | - | |
Apr 16, 2025 | - | - | - | |
Mar 19, 2025 | - | - | - | |
 | Oct 24, 2024 | Jan 14, 2022 | Series B | $140M |
Aug 26, 2024 | - | - | - |
Team profile of Foresite Capital
Foresite Capital has a team of 48 membersÌýincluding 18 Partners, 2 Venture Partners and 11 PrincipalsÌýlocated in United States. Foresite Capital's team sits on the board of 2 companies.Here is a list of top team members in Foresite Capital:
Name | Designation | Location | Board Memberships | Contact details |
|---|---|---|---|---|
Partner | - | and Evonetix | ||
Partner | San Francisco | - | ||
Partner | Philadelphia | - | ||
Partner | Greenbrae | - | ||
Partner | Los Angeles | - | ||
Partner | San Francisco | - | ||
Partner | West Point | - | ||
Partner | New York City | - | ||
Partner | San Francisco | - | ||
Partner | Hartford | - | ||
Partner | New Haven | - |
Get the full list of Foresite Capital's team & partners for free. Download now!Co-investors of Foresite Capital
Over the past 13 years, 790 investors have co-invested in Foresite Capital's portfolio companies.
- Invested before Foresite Capital:ÌýHHS, Google Ventures and 290 others have invested in rounds before Foresite Capital. There are 12 companies where HHS has invested before Foresite Capital and 9 companies where Google Ventures has invested before Foresite Capital.
- Top Co-investors of Foresite Capital:Ìý246 investors entered a company along with Foresite Capital. These include investors like Orbimed (16 companies).
- Invested after Foresite Capital:ÌýA total of 252 investors have invested in Foresite Capital's portfolio after their investments. Top Investors include Fidelity Investments (8 companies), Casdin Capital (7 companies) and Janus Henderson Investors (6 companies).
Get full list of Foresite Capital's co-investors delivered to your inbox!
Recent News related to Foresite Capital
•
•
entarabi.com•Mar 18, 2025•Latigo Biotherapeutics, Qatar Investment Authority, Alexandria, 5AM Ventures and 8 others
•
FinSMEs•Mar 17, 2025•Latigo Biotherapeutics, Blue Owl, Deep Track Capital, Access Industries and 10 others
•
•
•
MedCity News•Feb 27, 2025•Eikon, T. Rowe Price, StepStone Group, Soros Capital Management and 7 others
•
•
FinSMEs•Feb 27, 2025•Eikon, University of California, T. Rowe Price, StepStone Group and 8 others
•
Pharmaceutical Technology•Feb 26, 2025•Eikon, Lux Capital, Alexandria, AME Cloud Ventures and 5 others
•
